Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia
- 1 October 2006
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 34 (10) , 1303-1311
- https://doi.org/10.1016/j.exphem.2006.05.012
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Antibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risksNephrology Dialysis Transplantation, 2005
- Anemia of Chronic DiseaseNew England Journal of Medicine, 2005
- Turning cells red: signal transduction mediated by erythropoietinTrends in Cell Biology, 2005
- Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferationBlood, 2003
- Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant ErythropoietinNew England Journal of Medicine, 2002
- Nitric Oxide Metabolism in Erythropoietin-Induced HypertensionHypertension, 1998
- Increased potency of an erythropoietin peptide mimetic through covalent dimerizationNature Biotechnology, 1997
- Small Peptides as Potent Mimetics of the Protein Hormone ErythropoietinScience, 1996
- Effect of purified recombinant human erythropoietin on anemia in rats with experimental renal failure induced by five-sixth nephrectomyBiotherapy, 1990
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983